What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally
Kathleen Goin, Chief Operating Officer of Palvella Therapeutics (NASDAQ:PVLA), reported the exercise of 4,302 stock options immediately converted and sold as common shares for a transaction value of approximately $476,000 according to the SEC Form 4 filing. Transaction summary Transaction value based on SEC Form 4 weighted average purchase price ($110.73). Key questions How does…
